RE:RE:Ph2 looks very good, just waiting on word of the remaining 5jojomarch wrote: Xmas/ New Year's "wish" list:
1. Finish Ph1b 5 remaining patient - 30 day look see A OKAY. High dose slows UUTUC confirmed.
2. Ph2 approval follows quickly in New Year
3. Partnership announced with cost sharing and support for Ph2.
3.1 Partnership includes licensing agreement for several global market regions. Large cash payment upfront.
4. Super compound results from TLT and PMR are stunning, more insights discovered.
5. Ph2 protocol includes means to better address UUTUC including pre-treat with the 2000 and re-treatments of compound with activation allowed.
6. Ph2 includes exploratory work on vaccine and/or immune system enhancements
7. GBM Ph1 pursued with 2000 pre-treat, PDC with Xray activation (with re-treats) and vaccine development. Partner with big pharma cost sharing with licensing option paid upfront.
All licensing/partnerships includes marketing, training, market development, royalties. branding etc.
2020 Big pharma GBM partner bids full take out. $30B offer is quickly out bid to $40B. Bidding erupts...
ME TOO
THANK YOU VESTOR
My Xmas/New Year's wish list:
All I ask is a chance to prove that money can't make me happy.